Jeung HC - Search Results

1

Ahn JR, Jung M, Kim C, Hong MH, Chon HJ, Kim HR, Jeung HC, Hyung WJ, Lee SS, Chung HC, Noh SH, Rha SY. Ahn JR, et al. Among authors: jeung hc. Cancer Res Treat. 2009 Jun;41(2):73-9. doi: 10.4143/crt.2009.41.2.73. Epub 2009 Jun 30. Cancer Res Treat. 2009. PMID: 19707504 Free PMC article.

2

Biological phenotype determination with ex vivo model in gastric cancer for matrix-metalloproteinase inhibitor treatment.

Rha SY, Jeung HC, Roh JK, Kim JJ, Noh SH, Min JS, Kim BS, Chung HC. Rha SY, et al. Among authors: jeung hc. Int J Mol Med. 2002 Sep;10(3):251-6. Int J Mol Med. 2002. PMID: 12165796

3

Infusional fluorouracil, etoposide, and cisplatin (FEP) in advanced and relapsed gastric cancer.

Sohn JH, Jeung HC, Shin HJ, Rha SY, Roh JK, Noh SH, Min JS, Kim BS, Jang WI, Chung HC. Sohn JH, et al. Among authors: jeung hc. Am J Clin Oncol. 2003 Apr;26(2):203-9. doi: 10.1097/00000421-200304000-00022. Am J Clin Oncol. 2003. PMID: 12714898 Clinical Trial.

4

Attenuation of telomerase activity by hammerhead ribozyme targeting human telomerase RNA induces growth retardation and apoptosis in human breast tumor cells.

Yeo M, Rha SY, Jeung HC, Hu SX, Yang SH, Kim YS, An SW, Chung HC. Yeo M, et al. Among authors: jeung hc. Int J Cancer. 2005 Apr 10;114(3):484-9. doi: 10.1002/ijc.20720. Int J Cancer. 2005. PMID: 15551309

5

Gene copy number change events at chromosome 20 and their association with recurrence in gastric cancer patients.

Yang SH, Seo MY, Jeong HJ, Jeung HC, Shin J, Kim SC, Noh SH, Chung HC, Rha SY. Yang SH, et al. Among authors: jeung hc. Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):612-20. Clin Cancer Res. 2005. PMID: 15701848

6

Cyclic induction of senescence with intermittent AZT treatment accelerates both apoptosis and telomere loss.

Ji HJ, Rha SY, Jeung HC, Yang SH, An SW, Chung HC. Ji HJ, et al. Among authors: jeung hc. Breast Cancer Res Treat. 2005 Oct;93(3):227-36. doi: 10.1007/s10549-005-5156-0. Breast Cancer Res Treat. 2005. PMID: 16132531

7

Intermediate dose 5-fluorouracil-induced encephalopathy.

Kim YA, Chung HC, Choi HJ, Rha SY, Seong JS, Jeung HC. Kim YA, et al. Among authors: jeung hc. Jpn J Clin Oncol. 2006 Jan;36(1):55-9. doi: 10.1093/jjco/hyi214. Epub 2006 Jan 25. Jpn J Clin Oncol. 2006. PMID: 16436463 Free article.

8

Alteration of hTERT full-length variant expression level showed different gene expression profiles and genomic copy number changes in breast cancer.

Rha SY, Jeung HC, Yang WI, Kim JJ, Oh TJ, An SW, Chung HC. Rha SY, et al. Among authors: jeung hc. Oncol Rep. 2006 Apr;15(4):749-55. Oncol Rep. 2006. PMID: 16525654

9

Ribonucleotide reductase M1 (RRM1) 2464G>A polymorphism shows an association with gemcitabine chemosensitivity in cancer cell lines.

Kwon WS, Rha SY, Choi YH, Lee JO, Park KH, Jung JJ, Kim TS, Jeung HC, Chung HC. Kwon WS, et al. Among authors: jeung hc. Pharmacogenet Genomics. 2006 Jun;16(6):429-38. doi: 10.1097/01.fpc.0000204999.29924.da. Pharmacogenet Genomics. 2006. PMID: 16708051

10

A phase II trial of weekly fractionated irinotecan and cisplatin for advanced gastric cancer.

Jeung HC, Rha SY, Noh SH, Roh JK, Chung HC. Jeung HC, et al. Cancer Chemother Pharmacol. 2007 Feb;59(3):313-20. doi: 10.1007/s00280-006-0272-z. Epub 2006 Jun 13. Cancer Chemother Pharmacol. 2007. PMID: 16770582 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

160 results

Search Page

Filters